GRANTS
| Identification of molecular determinants of cross-reactivity of T-cell receptors |
| Testing the hypothesis of immune privilege of bone marrow mesenchymal stem cells on a mouse model |
| Investigation of the involvement of the bone marrow niche regulating hematopoiesis in the development of relapses in patients with acute leukemia |
| Investigation of the mechanisms of immunomodulatory action of multipotent mesenchymal stromal cells injected into patients after transplantation of allogeneic hematopoietic stem cells |
| Minor histocompatibility antigen HA-1 as a target for immunotherapy of post-transplant relapses of acute leukemia |
| Search for key paratopes of T-cell receptors specific to the minor histocompatibility antigen HA-2 |
CONTRACTS ON SCIENTIFIC AND TECHNICAL COOPERATION
| Investigation of the T-cell immune response in peripheral blood mononuclear cell samples obtained during the clinical trial D8111C00003/CV03872097 "Simple blind randomized phase 1/2 trial to determine the safety and immunogenicity of a combination of AZD1222 and rAd26-S drugs administered under the "heterologous prime boost" scheme for the prevention of the new COVID-19 coronavirus infection in adults” |
| Scientific work on the analysis of samples of biological material (human venous blood) to identify T-cells specifically activated when stimulated by SARS-CoV-2 virus antigens using the ELISPOT method |
